Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity; D001500:BCG Vaccine; D002999:Clone Cells / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D005260:Female; D007942:Leukemia, Experimental / Q000401:mortality / Q000628:therapy*; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D008806:Mice, Inbred AKR; D008807:Mice, Inbred BALB C; D009163:Mycobacterium bovis / Q000276:immunology; D009368:Neoplasm Transplantation; D013154:Spleen / Q000276:immunology; D013997:Time Factors
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine